-
1
-
-
4143111667
-
Introduction: Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines
-
Rubin LJ. Introduction: diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004; 126 (1- s uppl): 7S-10S.
-
(2004)
Chest.
, vol.126
, Issue.1
, pp. 7S-10S
-
-
Rubin, L.J.1
-
2
-
-
33947697880
-
The natural course of progressive systemic sclerosis patients with interstitial lung involvement
-
Benan M, Hande I, Gul O. The natural course of progressive systemic sclerosis patients with interstitial lung involvement. Clin Rheumatol. 2007; 26 (3): 349-354.
-
(2007)
Clin Rheumatol.
, vol.26
, Issue.3
, pp. 349-354
-
-
Benan, M.1
Hande, I.2
Gul, O.3
-
3
-
-
0038799767
-
Interstitial lung disease in scleroderma
-
White B. Interstitial lung disease in scleroderma. Rheum Dis Clin North Am. 2003; 29 (2): 371-390.
-
(2003)
Rheum Dis Clin North Am.
, vol.29
, Issue.2
, pp. 371-390
-
-
White, B.1
-
4
-
-
34347266509
-
Changes in causes of death in systemic sclerosis, 1972-2002
-
Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis. 2007; 66 (7): 940-944.
-
(2007)
Ann Rheum Dis.
, vol.66
, Issue.7
, pp. 940-944
-
-
Steen, V.D.1
Medsger, T.A.2
-
5
-
-
84905647871
-
Predictors of mortality and progression in scleroderma-associated interstitial lung disease: A systematic review
-
Winstone TA, Assayag D, Wilcox PG, et al. Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review. Chest. 2014; 146 (2): 422-436.
-
(2014)
Chest.
, vol.146
, Issue.2
, pp. 422-436
-
-
Winstone, T.A.1
Assayag, D.2
Wilcox, P.G.3
-
6
-
-
79952717349
-
An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management
-
Raghu G, Collard HR, Egan JJ, et al; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183 (6): 788-824.
-
(2011)
Am J Respir Crit Care Med.
, vol.183
, Issue.6
, pp. 788-824
-
-
Raghu, G.1
Collard, H.R.2
Egan, J.J.3
-
7
-
-
84861162888
-
A multidimensional index and staging system for idiopathic pulmonary fibrosis
-
Ley B, Ryerson CJ, Vittinghoff E, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012; 156 (10): 684-691.
-
(2012)
Ann Intern Med.
, vol.156
, Issue.10
, pp. 684-691
-
-
Ley, B.1
Ryerson, C.J.2
Vittinghoff, E.3
-
8
-
-
0037383987
-
Idiopathic pulmonary fibrosis: A composite physiologic index derived from disease extent observed by computed tomography
-
Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med. 2003; 167 (7): 962-969.
-
(2003)
Am J Respir Crit Care Med.
, vol.167
, Issue.7
, pp. 962-969
-
-
Wells, A.U.1
Desai, S.R.2
Rubens, M.B.3
-
9
-
-
80051819865
-
Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis
-
du Bois RM, Weycker D, Albera C, et al. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011; 184 (4): 459-466.
-
(2011)
Am J Respir Crit Care Med.
, vol.184
, Issue.4
, pp. 459-466
-
-
Du Bois, R.M.1
Weycker, D.2
Albera, C.3
-
10
-
-
84899830690
-
6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis
-
du Bois RM, Albera C, Bradford WZ, et al. 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2014; 43 (5): 1421-1429.
-
(2014)
Eur Respir J.
, vol.43
, Issue.5
, pp. 1421-1429
-
-
Du Bois, R.M.1
Albera, C.2
Bradford, W.Z.3
-
11
-
-
84898755329
-
Predicting survival across chronic interstitial lung disease: The ILD-GAP model
-
Ryerson CJ, Vittinghoff E, Ley B, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest. 2014; 145 (4): 723-728.
-
(2014)
Chest.
, vol.145
, Issue.4
, pp. 723-728
-
-
Ryerson, C.J.1
Vittinghoff, E.2
Ley, B.3
-
12
-
-
84886777196
-
2013 classification criteria for systemic sclerosis: An American College of Rheumatology/European League against Rheumatism collaborative initiative
-
van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013; 65 (11): 2737-2747.
-
(2013)
Arthritis Rheum.
, vol.65
, Issue.11
, pp. 2737-2747
-
-
Van Den Hoogen, F.1
Khanna, D.2
Fransen, J.3
-
13
-
-
0018887574
-
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
-
Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee
-
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980; 23 (5): 581-590.
-
(1980)
Arthritis Rheum.
, vol.23
, Issue.5
, pp. 581-590
-
-
-
14
-
-
84881669432
-
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias
-
Travis WD, Costabel U, Hansell DM, et al; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013; 188 (6): 733-748.
-
(2013)
Am J Respir Crit Care Med.
, vol.188
, Issue.6
, pp. 733-748
-
-
Travis, W.D.1
Costabel, U.2
Hansell, D.M.3
-
15
-
-
21744439879
-
Standardisation of the single-breath determination of carbon monoxide uptake in the lung
-
Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005; 26 (4): 720-735.
-
(2005)
Eur Respir J.
, vol.26
, Issue.4
, pp. 720-735
-
-
Macintyre, N.1
Crapo, R.O.2
Viegi, G.3
-
16
-
-
21744460289
-
Standardisation of spirometry
-
Miller MR, Hankinson J, Brusasco V, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005; 26 (2): 319-338.
-
(2005)
Eur Respir J.
, vol.26
, Issue.2
, pp. 319-338
-
-
Miller, M.R.1
Hankinson, J.2
Brusasco, V.3
-
17
-
-
21744434300
-
Standardisation of the measurement of lung volumes
-
Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005; 26 (3): 511-522.
-
(2005)
Eur Respir J.
, vol.26
, Issue.3
, pp. 511-522
-
-
Wanger, J.1
Clausen, J.L.2
Coates, A.3
-
18
-
-
0036644465
-
ATS statement: Guidelines for the six-minute walk test
-
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166 (1): 111-117.
-
(2002)
Am J Respir Crit Care Med.
, vol.166
, Issue.1
, pp. 111-117
-
-
-
19
-
-
67650349068
-
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): A multicentre randomised placebo-controlled trial
-
King TE Jr, Albera C, Bradford WZ, et al; INSPIRE Study Group. effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet. 2009; 374 (9685): 222-228.
-
(2009)
Lancet.
, vol.374
, Issue.9685
, pp. 222-228
-
-
King, T.E.1
Albera, C.2
Bradford, W.Z.3
-
20
-
-
0345824715
-
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
-
Raghu G, Brown KK, Bradford WZ, et al; Idiopathic Pulmonary Fibrosis Study Group. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2004; 350 (2): 125-133.
-
(2004)
N Engl J Med.
, vol.350
, Issue.2
, pp. 125-133
-
-
Raghu, G.1
Brown, K.K.2
Bradford, W.Z.3
-
21
-
-
44449152061
-
Interstitial lung disease in systemic sclerosis: A simple staging system
-
Goh NS, Desai SR, Veeraraghavan S, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med. 2008; 177 (11): 1248-1254.
-
(2008)
Am J Respir Crit Care Med.
, vol.177
, Issue.11
, pp. 1248-1254
-
-
Goh, N.S.1
Desai, S.R.2
Veeraraghavan, S.3
-
22
-
-
84055212479
-
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease
-
De Santis M, Bosello SL, Peluso G, et al. Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease. Clin Respir J. 2012; 6 (1): 9-17.
-
(2012)
Clin Respir J.
, vol.6
, Issue.1
, pp. 9-17
-
-
De Santis, M.1
Bosello, S.L.2
Peluso, G.3
-
23
-
-
84871132776
-
Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease
-
Moore OA, Goh N, Corte T, et al. Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford). 2013; 52 (1): 155-160.
-
(2013)
Rheumatology (Oxford).
, vol.52
, Issue.1
, pp. 155-160
-
-
Moore, O.A.1
Goh, N.2
Corte, T.3
|